Log in
Enquire now
‌

US Patent 8158647 Substituted pyrrolopyridines and pyrazolopyridines as kinase modulators

Patent 8158647 was granted and assigned to SGX Pharmaceuticals on April, 2012 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors
Is a
Patent
Patent
0
Current Assignee
‌
SGX Pharmaceuticals
0
Date Filed
May 29, 2008
0
Date of Patent
April 17, 2012
0
Patent Application Number
12129546
0
Patent Citations Received
‌
US Patent 11780823 Indazole-3-carboxamides and their use as Wnt/β-catenin signaling pathway inhibitors
‌
US Patent 12012401 Process for preparing N-(5-(3-(7-(3-fluorophenyl)-3H-imidazo[4,5-c]pyridin-2-yl)-1H-indazol-5-yl)pyridin-3-yl)-3-methylbutanamide
0
Patent Inventor Names
Gavin Hirst
0
Andreas Gosberg
0
Ruo W. Steensma
0
Stefan N. Gradl
0
Stephanie A. Hopkins
0
Jeffrey M. Blaney
0
Johnny Uy
0
Paul A. Sprengeler
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
8158647
0
Patent Primary Examiner
‌
Janet Andres
0

Find more entities like US Patent 8158647 Substituted pyrrolopyridines and pyrazolopyridines as kinase modulators

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.